Evidence map›Paper›PMID 33790021›Full record

ArticleScience translational medicine2021

Increasing breast milk betaine modulates

Silvia Ribo, David Sánchez-Infantes, Laura Martinez-Guino, Izaskun García-Mantrana, Marta Ramon-Krauel, Mireia Tondo, Erland Arning, Miquel Nofrarías, Óscar Osorio-Conles, Antonio Fernández-Pérez and 14 more

Open access · greenAbstract read
In one paragraph

Article in Science translational medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
11.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Big lessons from the littleFrontiers in immunology · 2025
    Review
  14. Frontiers in neuroscience · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. International journal of molecular sciences · 2023
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 11 institutions in 2 countries.

Silvia RiboEndocrinology Department, Institut de Recerca Sant Joan de Déu, 08950 Barcelona, Spain.ORCID 0000-0001-8983-827X
David Sánchez-InfantesEndocrinology Department, Institut de Recerca Sant Joan de Déu, 08950 Barcelona, Spain.ORCID 0000-0001-6086-7501
Laura Martinez-GuinoEndocrinology Department, Institut de Recerca Sant Joan de Déu, 08950 Barcelona, Spain.
Izaskun García-MantranaDepartment of Biotechnology, Institute of Agrochemistry and Food Technology-National Research Council (IATA-CSIC), 46980 Valencia, Spain.
Marta Ramon-KrauelEndocrinology Department, Institut de Recerca Sant Joan de Déu, 08950 Barcelona, Spain.ORCID 0000-0003-3027-9105
Mireia TondoInstitute of Metabolic Disease, Baylor Scott and White Research Institute, Dallas, TX 75204, USA.
Erland ArningInstitute of Metabolic Disease, Baylor Scott and White Research Institute, Dallas, TX 75204, USA.ORCID 0000-0002-0934-0808
Miquel NofraríasIRTA, Centre de Recerca en Sanitat Animal (CReSA, IRTA-UAB), Campus de la Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain.ORCID 0000-0002-7983-1389
Óscar Osorio-ConlesEndocrinology Department, Institut de Recerca Sant Joan de Déu, 08950 Barcelona, Spain.ORCID 0000-0002-0285-5526
Antonio Fernández-PérezInstituto de Investigaciones Biomédicas Alberto Sols, Consejo Superior de Investigaciones Científicas/Universidad Autónoma de Madrid (CSIC/UAM), 28029 Madrid, Spain.ORCID 0000-0001-6866-5824
Pedro González-TorresBioinformatics and Genomics Program, Centre for Genomic Regulation (CRG), 08003 Barcelona, Spain.ORCID 0000-0003-3270-1859
Judith CebriàEndocrinology Department, Institut de Recerca Sant Joan de Déu, 08950 Barcelona, Spain.
Aleix Gavaldà-NavarroCIBER Fisiopatologia de la Obesidad y Nutrición, 28029 Madrid, Spain.ORCID 0000-0001-8421-3174
Empar ChenollBiopolis S.L.-ADM, 46980 Paterna, Spain.ORCID 0000-0002-6891-3573
Elvira IsganaitisResearch Division, Joslin Diabetes Center, Harvard Medical School, Boston, MA 02215, USA.
Francesc VillarroyaCIBER Fisiopatologia de la Obesidad y Nutrición, 28029 Madrid, Spain.ORCID 0000-0003-1266-9142
Mario VallejoInstituto de Investigaciones Biomédicas Alberto Sols, Consejo Superior de Investigaciones Científicas/Universidad Autónoma de Madrid (CSIC/UAM), 28029 Madrid, Spain.ORCID 0000-0002-6422-0323
Joaquim SegalésUAB, Centre de Recerca en Sanitat Animal (CReSA, IRTA-UAB), Campus de la Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain.ORCID 0000-0002-1539-7261
Josep C Jiménez-ChillarónEndocrinology Department, Institut de Recerca Sant Joan de Déu, 08950 Barcelona, Spain.
Teodoro BottiglieriInstitute of Metabolic Disease, Baylor Scott and White Research Institute, Dallas, TX 75204, USA.ORCID 0000-0002-4199-7551
Ellen W DemerathDivision of Epidemiology and Community Health, The University of Minnesota School of Public Health, Minneapolis, MN 55455, USA.ORCID 0000-0002-4585-4064
David A FieldsDepartment of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.ORCID 0000-0002-6845-1196
María Carmen ColladoDepartment of Biotechnology, Institute of Agrochemistry and Food Technology-National Research Council (IATA-CSIC), 46980 Valencia, Spain.ORCID 0000-0002-6204-4864
Carles LerinEndocrinology Department, Institut de Recerca Sant Joan de Déu, 08950 Barcelona, Spain. clerin@fsjd.org.ORCID 0000-0003-0950-4363
Institut de Recerca Sant Joan de DéuBaylor Scott & White Health · USInstituto de Salud Carlos III · ESInstituto de Agroquímica y Tecnología de Alimentos · ESInstituto de Investigaciones Biomédicas Sols-Morreale · ESUniversitat Autònoma de Barcelona · ESBiopolis (Spain) · ESCentre for Genomic Regulation · ESJoslin Diabetes Center · USUniversity of Minnesota · USUniversity of Oklahoma Health Sciences Center · US

Funding

Maternal Obesity, Milk Composition, and Infant GrowthR01HD080444 · NICHD · UNIVERSITY OF MINNESOTA · PI ELLEN W. DEMERATH, DAVID A FIELDS · 2014 to 2026
$6.4M
NICHD NIH HHS R01 HD080444
6 · The paper itself

Abstract

Accelerated postnatal growth is a potentially modifiable risk factor for future obesity. To study how specific breast milk components contribute to early growth and obesity risk, we quantified one-carbon metabolism-related metabolites in human breast milk and found an inverse association between milk betaine content and infant growth. This association was replicated in an independent and geographically distinct cohort. To determine the potential role of milk betaine in modulating offspring obesity risk, we performed maternal betaine supplementation experiments in mice. Higher betaine intake during lactation increased milk betaine content in dams and led to lower adiposity and improved glucose homeostasis throughout adulthood in mouse offspring. These effects were accompanied by a transient increase in

Indexed as

BetaineMilk, HumanAkkermansiaAnimalsDiet, High-FatFemaleLactationMiceBetaine

Identifiers

PMID33790021
PMCPMC8823629
OpenAlexW3149710726

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.